Sentara Infusion Services recalls Diphenhydramine 18mg in 3.6ML NS SYRINGE, antihistamine, Rx Only, Sentara Home Infusion Pharmacy Services, 535 Independe
Recalled February 22, 2023 · FDA recall D-0289-2023 · Sentara Infusion Services
Hazard
Lack of sterility assurance · FDA Class II
Units
15 bags
Sold at
Dispensed to Patients Nationwide.
Description
Lack of sterility assurance
Product
Diphenhydramine 18mg in 3.6ML NS SYRINGE, antihistamine, Rx Only, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320,
Manufacturer(s)
Sentara Infusion Services
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →